Our cross-functional panel discusses the US landscape in rare disease and the challenges for health care access, creating value propositions and solutions, and the role of innovative real-world data strategies and communication channels for optimal engagement of all stakeholders.
• Understand disparities in health outcomes and health access that drive patient centricity in rare disease
• Recognize the challenges for using HEOR and RWE in value propositions in rare disease
• Identify strategies to address these challenges and increase the role of HEOR and RWE in supporting market access and reimbursement for orphan drugs
The Collective Intelligence Webinars leverage the global expertise of the Healthcare Consultancy Group (HCG) to provide leading professionals across pharma and biotech with thought-leadership examples of future thinking, collaboration, and communication excellence.
HCG is a global leader in medical communications, comprising 7 interconnected agencies with distinct personalities and complementary skills.
The depth of our expertise allows us to configure custom solutions to meet your scientific, regulatory, and digital needs. Discrete offices and robust processes ensure the confidentiality of your data and programs.
We give your programs the profile they deserve by building your team with you in mind.
Healthcare Consultancy Group (HCG) is a global leader in medical communications – 8 agencies united in a common vision. To accelerate product understanding and acceptance, bringing clients’ medicines closer to the patients who need them. With global offices of around 1000+ staff spanning North America, Europe and Asia, HCG is an incubator for the relentlessly curious. Our appetite for creating strategies that lead to better patient outcomes is never satisfied.
